Tag:
lung cancer
Latest Headlines
Latest Headlines
Biomarkers support lung cancer diagnosis, treatment
Early diagnosis of lung cancer is important for good outcomes for patients, as is tailoring the treatment to the patient, and new biomarkers could support both of these routes.
Roche's Tarceva wins NICE nod for first-line use
After an initial draft guidance rejecting the lung cancer treatment, the National Institute for Health and Clinical Excellence now says Tarceva should be available as a first-line treatment.
Mesothelioma biomarkers at lung conference
Malignant pleural mesothelioma is the most common form of mesothelioma, but diagnosis can be delayed. Biomarkers are in development, and some of those presented at the 3rd European Lung Cancer Conference may help to make this diagnosis earlier.
There may be more to mesothelioma than mesothelin
Mesothelin has been used as a biomarker for mesothelioma, including in marketed tests such as Fujirebio Diagnostics' Mesomark test, but a study published in the Journal of Clinical Oncology has...
Disappointing cancer data triggers sharp drop in Peregrine shares
On Friday morning you would have had to dig deep into Peregrine Pharmaceuticals' release on its data for its lung cancer drug bavituximab , but once in you would have found that the...
Oncothyreon shares routed as Stimuvax PhIII trial soldiers on
Merck KGaA told analysts today that after assessing its late-stage study for the lung cancer vaccine Stimuvax in a second interim analysis, investigators were told to push on to an ultimate read-out...
Lee Hood startup grabs $10M to advance class of protein-capture agents
Biotech visionary Lee Hood's startup Integrated Diagnostics has reeled in fresh capital to roll into commercial mode with its novel protein-catalyzed capture (PCC) agents.
Genetic test could up outcomes after lung cancer surgery
When patients present with early-stage non-small-cell lung cancer, doctors assess the tumors by looking at their size, location and appearance, and use this information to decide what to do after
Avila pockets payment in $209M lung cancer drug deal
Avila Therapeutics ( a 2010 Fierce 15 company ) has banked $4 million from partner Clovis Oncology ( $CLVS ). The payment was made as part of Avila's $209 million alliance with Clovis ( a 2009 Fierce 15
Researchers find new lung cancer biomarkers
According to the cancer stem cell theory, cancer stem cells or tumor-initiating cells promote tumor growth and metastasis. A team of Singaporean researchers have linked the stem cell surface
